The effect of recombinant human osteogenic protein-1 on allograft incorporation.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Bone and Joint Surgery-british Volume

• Publication date

  2005-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1302/0301-620X.87B9.15955PMID 16129761
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effect of Osteogenic Protein-1 Dosing Regimen on Ectopic Bone Formation

  2004cited by this paper
• The effect of recombinant human osteogenic protein‐1 (bone morphogenetic protein‐7) impregnation on allografts in a canine intercalary bone defect

  2002cited by this paper
• The effect of recombinant human bone morphogenetic protein‐2 on femoral reconstruction with an intercalary allograft in a dog model

  2001cited by this paper
• Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.

  2001cited by this paper
• The Effect of Osteogenic Protein-1 on the Healing of Segmental Bone Defects Treated with Autograft or Allograft Bone

  2001cited by this paper
• Histomorphometric description of allograft bone remodeling and union in a canine segmental femoral defect model: A comparison of rhBMP‐2, cancellous bone graft, and absorbable collagen sponge

  2001cited by this paper
• Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-κB Ligand.

  2001cited by this paper
• Complications of Irradiated Allografts in Orthopaedic Tumor Surgery

  2000cited by this paper
• Bone Graft Incorporation: Effects of Osteogenic Protein-1 and Impaction

  2000cited by this paper
• Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect.

  1999cited by this paper
• Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.

  1999cited by this paper
• Effects of rhBMP-2 and osteopromotive membranes on experimental bone grafting.

  1999cited by this paper
• TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.

  1999cited by this paper
• Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites.

  1999cited by this paper
• Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect

  1999cited by this paper
• Inductive properties of recombinant human BMP-2 produced in a bacterial expression system.

  1998cited by this paper
• Potential Role of Bone Morphogenetic Proteins in Fracture Healing

  1998cited by this paper
• Initiation of fracture repair by bone morphogenetic proteins.

  1998cited by this paper
• Recycled dentin root matrix for a carrier of recombinant human bone morphogenetic protein.

  1998cited by this paper
• Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model.

  1997cited by this paper
• Evaluation of Heterotopic Bone Formation Induced by Squalane and Bone Morphogenetic Protein Composite

  1997cited by this paper
• Stimulation of Proteoglycan Synthesis in Explants of Porcine Articular Cartilage by Recombinant Osteogenic Protein-1 (Bone Morphogenetic Protein-7)*

  1997cited by this paper
• Composites of bone morphogenetic protein (BMP) and type IV collagen, coral-derived coral hydroxyapatite, and tricalcium phosphate ceramics

  1996cited by this paper
• Bone morphogenetic protein-2: biology and applications.

  1996cited by this paper
• Use of Bone Morphogenetic Protein-2 in the Rabbit Ulnar Nonunion Model

  1996cited by this paper
• Demineralized bone matrix supplied by bone banks for a carrier of recombinant human bone morphogenetic protein (rhBMP-2): a substitute for autogeneic bone grafts.

  1996cited by this paper
• Long-Term Results of Allograft Replacement in the Management of Bone Tumors

  1996cited by this paper
• Stimulatory effect of bone morphogenetic protein‐2 on osteoclast‐like cell formation and bone‐resorbing activity

  1995cited by this paper
• Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).

  1994cited by this paper
• Osteogenic protein-1 (BMP-7) inhibits cell proliferation and stimulates the expression of markers characteristic of osteoblast phenotype in rat osteosarcoma (17/2.8) cells.

  1994cited by this paper
• Bone repair in the otic capsule of the rabbit.

  1992cited by this paper
• Distribution and orientation of bone in the human lumbar vertebral centrum.

  1992cited by this paper
• Cement or Cementless Fixation in Total Knee Arthroplasty?

  1991cited by this paper
• Induction of callus formation by implants of bone morphogenetic protein and associated bone matrix noncollagenous proteins.

  1988cited by this paper
• Dose-dependence of and threshold for optimal bone induction by collagenous bone matrix and osteogenin-enriched fraction.

  1988cited by this paper
• Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs.

  1987cited by this paper
• In vitro transformation of mesenchymal cells derived from embryonic muscle into cartilage in response to extracellular matrix components of bone.

  1984cited by this paper
• Beta-tricalcium phosphate delivery system for bone morphogenetic protein.

  1984cited by this paper
• Extracellular bone matrix-derived growth factor.

  1982cited by this paper
• Biochemical sequences in the transformation of normal fibroblasts in adolescent rats.

  1972cited by this paper
• Bone: Formation by Autoinduction

  1965cited by this paper

• Supramolecular Self-Assembling Peptides to Deliver Bone Morphogenetic Proteins for Skeletal Regeneration.

  2020cites this paper
• Growth Factors, Carrier Materials, and Bone Repair.

  2020cites this paper
• Результати використання репаративної методики лікування дисрегенерацій кісткової тканини

  2015cites this paper
• Experiencia con BMP-7 en el tratamiento de las seudoartrosis infectadas

  2010cites this paper
• Osteogenic Protein-1 Associated with Mesenchymal Stem Cells Promote Bone Allograft Integration

  2010cites this paper
• Instrumented One and Two Level Posterolateral Fusions With Recombinant Human Bone Morphogenetic Protein-2 and Allograft: A Computed Tomography Study

  2010cites this paper
• Bone morphogenetic proteins and tissue engineering: future directions.

  2009cites this paper
• OP-1 application in bone allograft integration: preliminary results in sheep experimental surgery.

  2008cites this paper
• Extracortical bone-bridging fixation with use of cortical allograft and recombinant human osteogenic protein-1.

  2007cites this paper
• Extracortical Bone-Bridging Fixation with Use of Cortical Allograft and rhOP-1

  2007cites this paper